Regulatory frameworks are no longer simply gatekeepers of safety; they increasingly help ensure that new technologies are easier to understand, simpler to use, and more compatible with real-world healthcare settings. The post Regulatory Innovation as a Catalyst: How New Compliance Strategies Are Speeding Up Healthcare Technology Adoption appeared first on MedCity News.
Despite the silk masks, oils, and sleepy girl mocktails swirling around social media, one of the greatest causes of non-restorative sleep is rarely mentioned by wellness influencers online: actual sleep disorders. The post The Sleep Crisis We May Be Missing: Why Millions of Americans Remain Undiagnosed appeared first on MedCity News.
By KIM BELLARD You know, it’s gotten to the point when I just try to tune out the things Robert F. Kennedy Jr. says. “Schizophrenia can be cured with a keto diet”? Sure, whatever. “The war on protein is over”? Who even knew there was such a war? The carnivore diet is a great way…
Despite a slight decline in breach numbers, a new report by The HIPAA Journal highlights ongoing risks, such as increased unauthorized access incidents
Innovation consortium has grown to 14 health systems with the addition of Yale New Haven Health System, Keck Medicine of USC, and Hartford HealthCare
Honoring Tom Racobaldo: Crothall CEO to Retire After Decades of Leadership In 1979, Tom Racobaldo refinished hospital floors and cleaned patient rooms as a Crothall management trainee. Six months later, he received his first assignment: managing a 50-bed hospital with 10 employees in northeast Philadelphia. Forty-six years later, Racobaldo will retire as Crothall’s chief executive officer. Well-known for his humility, Racobaldo will complete nearly a half-century in the business at the top…
Over-the-counter continuous glucose monitors have been available for people with and without diabetes for more than a year now — but the data they collect doesn’t seem to be as useful for nondiabetic users, according to new research from Mass General Brigham. The post Over-the-Counter CGMs Are Here — But Do They Really Make Sense…
Amylyx Pharmaceuticals’ avexitide led to statistically significant and clinically meaningful reductions in hypoglycemic events in patients with post-bariatric hypoglycemia (PBH). This peptide drug, a GLP-1 antagonist, was acquired from Eiger BioPharmaceuticals in 2024. The post Amylyx Plans FDA Filing After GLP-1 Drug Hits Trial Goals in Rare Metabolic Condition appeared first on MedCity News.
[Sponsored] Healthcare in the U.S. today exists in a complex, fragmented and costly system, and the people this system is designed for deserve a holistic approach to best address their individual health needs. The post Rethinking The Entry Point to Healthcare in America: Collaboration in Communities appeared first on MedCity News.
This State and Federal Reproductive Rights Litigation tracker aggregates information about ongoing litigation regarding abortion bans and restrictions, FDA approval of Mifepristone (an abortion pill) and other federal regulations.